Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3046870	s-ttgabg	— (—)	17455	18973	100.00%	Distribution not available
3046870	s-ttgabg	u/ml (u/ml)	253	294	5.44%
3046870	s-ttgabg	eliau/ml (u/ml)	32	34	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Examination and observation for other reasons

2376

6042

2.48

310.41

1.1

7.29

8.09

u/ml

0.05

Type 1 diabetes, wide definition, subgroup 1

1196

3422

3.81

307.65

1.2

1.1

8.88

14.64

u/ml

0.21

Type 1 diabetes, wide definition

1225

3592

3.70

307.65

1.2

1.1

8.88

13.95

u/ml

0.19

Type 1 diabetes

1325

4046

3.52

307.65

1.2

1.1

8.36

13.82

u/ml

0.22

Non-invasive ventilation

1004

2679

3.77

296.57

1.1

—

3.79

—

Sub-endpoint used in defining T1D endpoints

1329

4447

3.12

295.47

1.2

1.1

7.45

12.71

u/ml

0.24

Insulin, fast-acting

1508

5516

2.89

294.15

1.2

1.1

6.63

11.04

u/ml

0.25

Insulin, fast-acting or short human

1512

5598

2.85

287.90

1.2

1.1

6.64

13.83

u/ml

0.42

Autoimmune diseases excluding thyroid diseases

3786

10842

1.99

287.18

1.1

14.08

7.04

u/ml

0.51

143

Autoimmune diseases excluding thyroid diseases, strict definition

3668

10539

1.99

278.93

1.1

14.24

7.17

u/ml

0.50

140

Pain in joint

2168

6247

2.38

265.25

1.1

8.78

10.02

u/ml

0.06

104

Type 1 diabetes, strict (exclude DM2)

717

1807

4.47

259.81

1.2

1.1

1.55

18.21

u/ml

—

Type 1 diabetes, definitions combined

719

1822

4.44

258.50

1.2

1.1

1.55

18.21

u/ml

—

Autoimmune diseases

3935

10956

1.88

247.77

1.1

16.53

7.04

u/ml

0.68

143

Anaemias

1057

2202

3.37

241.73

1.1

7.72

23.99

u/ml

0.43

Type 1 diabetes, strict definition

626

1545

4.62

234.23

1.2

1.1

1.64

19.86

u/ml

—

Insulin, fast-acting (human)

737

2026

3.95

233.91

1.2

1.1

12.41

2.51

u/ml

—

Used for control exclusion in common control thyroid runs

3705

10241

1.88

232.69

1.1

16.98

7.69

u/ml

0.55

129

Depression

3391

12692

1.89

231.90

1.1

10.18

9.14

u/ml

0.05

193

Type 1 diabetes, strict definition, subgroup 1

600

1459

4.70

229.25

1.2

1.1

1.64

21.87

u/ml

—

Mood [affective] disorders

3566

12997

1.85

227.01

1.1

8.46

8.85

u/ml

0.02

200

Mood disorders

3569

13004

1.85

226.31

1.1

8.46

8.86

u/ml

0.02

200

Mood disorders, excluding more controls

3280

10737

1.91

225.17

1.1

9.21

8.58

u/ml

0.03

165

Insulin, intermediate and long-acting

1825

8079

2.30

224.12

1.2

1.1

19.18

10.61

u/ml

0.26

124

Anxiety (asthma-related co-morbidities)

2277

8905

2.09

210.29

1.1

5.55

9.57

u/ml

0.37

141

Other diseases of intestines

3633

12025

1.80

205.30

1.1

4.09

14.03

u/ml

1.40

174

Insulin, combination of fast acting with intermediate-acting or long-acting

1950

8746

2.12

195.01

1.2

1.1

16.45

10.53

u/ml

0.20

125

Insulin medication

1950

8097

2.13

193.33

1.2

1.1

16.45

8.64

u/ml

0.29

119

All anxiety disorders

2322

9635

2.00

193.30

1.1

5.41

10.84

u/ml

0.54

153

Anxiety disorders, excluding more controls

2851

10355

1.87

188.79

1.1

9.47

10.77

u/ml

0.06

158

Endocrine, nutritional and metabolic diseases

2989

8362

1.86

183.31

1.1

3.70

14.40

u/ml

1.18

121

Neurotic, stress-related and somatoform disorders

3084

12540

1.79

179.80

1.1

9.66

10.80

u/ml

0.05

194

Coeliac disease

654

1997

3.60

178.30

1.3

1.1

47.69

0.97

u/ml

2.13

Anxiety disorders

3098

12635

1.78

176.74

1.1

9.47

10.80

u/ml

0.06

194

Irritable bowel syndrome

1076

4368

2.59

170.32

1.1

0.97

7.43

u/ml

0.66

Abdominal and pelvic pain

3295

9717

1.74

161.88

1.1

9.61

12.97

u/ml

0.16

159

Care involving use of rehabilitation procedures

2116

10780

1.92

160.48

1.1

12.55

6.46

u/ml

0.21

165

Other soft tissue disorders, not elsewhere classified

3016

10854

1.76

159.83

1.1

1.61

10.99

u/ml

1.91

167

Low back pain

2360

10019

1.86

157.79

1.1

11.01

5.57

u/ml

0.24

144

Other functional intestinal disorders

1467

6638

2.18

157.52

1.1

2.75

12.47

u/ml

0.99

Symptoms and signs involving the digestive system and abdomen

3283

9728

1.72

156.58

1.1

10.28

12.97

u/ml

0.12

159

Recurrent or chronic depression

1471

4956

2.22

156.51

1.1

11.56

6.50

u/ml

0.19

Headache

2265

10440

1.86

153.88

1.1

12.42

11.06

u/ml

0.04

149

Pain in limb

2506

10218

1.82

153.74

1.1

1.35

11.41

u/ml

1.92

156

Constipation

2661

10938

1.78

153.32

1.1

4.33

10.20

u/ml

0.70

158

Diseases of oesophagus, stomach and duodenum

3283

12031

1.69

152.32

1.1

6.64

7.84

u/ml

0.09

167

Other antidepressants

3230

10053

1.71

150.78

1.1

8.15

12.17

u/ml

0.26

146

Diverticular disease of intestine

1926

6672

1.96

147.81

1.1

1.17

12.06

u/ml

1.53

102

Dorsalgia

3239

10590

1.69

146.06

1.1

10.20

5.45

u/ml

0.25

155

Other specific joint derangements/joint disorders

2519

9654

1.79

145.54

1.1

7.29

13.40

u/ml

0.39

135

Depression or dysthymia

2226

6782

1.88

144.20

1.1

10.83

6.20

u/ml

0.23

Pain in throat and chest

2705

9633

1.75

142.80

1.1

2.44

7.69

u/ml

0.99

145

Depression medications

1181

2527

2.42

140.70

1.1

2.57

6.50

u/ml

0.45

Other anxiety disorders

1677

7745

1.98

138.30

1.1

7.40

8.18

u/ml

0.05

119

Lower back pain or/and sciatica

3152

13516

1.65

136.67

1.1

8.88

9.08

u/ml

0.01

195

Other dorsopathies, not elsewhere classified

3287

10693

1.65

135.75

1.1

15.69

5.43

u/ml

0.51

156

Gastrointestinal diseases

2144

5863

1.87

134.03

1.1

14.32

8.59

u/ml

0.19

Pain (limb, back, neck, head abdominally)

2336

6575

1.81

132.81

1.1

12.04

9.91

u/ml

0.07

108

Hypothyroidism (congenital or acquired)

1008

2402

2.49

132.09

1.1

16.72

19.55

u/ml

0.05

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2941

12939

1.66

132.04

1.1

28.28

5.73

u/ml

1.18

185

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2923

10863

1.68

131.46

1.1

10.50

7.20

u/ml

0.18

176

Hypothyroidism and >3 levothyroxin purchases

995

2387

2.48

128.91

1.1

16.18

19.55

u/ml

0.07

Hypothyroidism, levothyroxine purchases

995

2387

2.48

128.91

1.1

16.18

19.55

u/ml

0.07

Diseases of the digestive system

1351

6739

2.06

127.49

1.2

1.1

34.59

1.18

u/ml

2.08

Diabetes medication

3171

12073

1.63

126.95

1.1

17.84

9.81

u/ml

0.35

198

Diabetes, insulin treatment (Kela reimbursement)

2990

11376

1.64

123.33

1.1

10.50

8.61

u/ml

0.10

180

General symptoms and signs

3517

11297

1.59

122.33

1.1

7.86

10.71

u/ml

0.17

165

Other headache syndromes

1444

7508

1.99

122.16

1.1

1.26

7.99

u/ml

1.44

106

Diabetes mellitus

3172

11979

1.61

121.29

1.1

19.26

9.89

u/ml

0.39

197

Metabolic disorders

2741

10428

1.66

120.64

1.1

15.89

5.29

u/ml

0.54

156

Asthma

2567

8255

1.70

118.79

1.1

22.40

4.62

u/ml

0.68

138

Personality disorders, excluding more controls

924

4115

2.34

118.35

1.1

1.26

5.37

u/ml

0.65

Asthma (mode)

2523

8291

1.71

118.28

1.1

21.84

4.60

u/ml

0.67

139

Asthma, excluding more controls

2518

8026

1.71

117.54

1.1

22.40

4.66

u/ml

0.68

134

Other intervertebral disc disorders

2406

8812

1.70

115.38

1.1

1.93

5.04

u/ml

0.75

128

Pure hypercholesterolaemia

1934

7346

1.80

115.16

1.1

12.68

5.30

u/ml

0.31

116

Dermatitis and eczema

3317

14150

1.56

114.51

1.1

6.42

11.14

u/ml

0.42

208

Diabetes, varying definitions

3122

11947

1.59

113.50

1.1

19.79

9.93

u/ml

0.40

196

Codeine

2955

10271

1.61

111.18

1.1

3.17

8.48

u/ml

0.91

172

Neurological diseases, wide definition

1190

2825

2.17

111.04

1.1

1.02

15.45

u/ml

0.95

Tramadol

2269

8738

1.70

109.48

1.1

8.97

4.69

u/ml

0.22

139

Symptoms and signs involving the circulatory and respiratory systems

3283

10658

1.57

109.29

1.1

12.88

9.80

u/ml

0.16

163

Gastro-oesophageal reflux disease

1916

9882

1.76

109.09

1.1

1.44

7.48

u/ml

1.22

141

Other diseases of hard tissues of teeth

1927

8352

1.76

107.15

1.1

8.99

6.70

u/ml

0.12

135

Selective serotonin reuptake inhibitors

3028

10230

1.58

105.93

1.1

1.10

12.17

u/ml

1.91

146

Soft tissue disorders

3271

11093

1.56

105.88

1.1

5.65

10.76

u/ml

0.43

171

Codeine or tramadol medication

3390

12398

1.54

105.68

1.1

2.84

10.65

u/ml

1.52

203

Hypothyroidism, drug reimbursement

539

1348

2.98

104.80

1.1

1.11

10.67

u/ml

—

Disorders of lipoprotein metabolism and other lipidaemias

2161

8133

1.70

104.05

1.1

12.48

4.98

u/ml

0.33

125

Any reimbursement code in KELA

2110

6236

1.73

102.15

1.1

13.70

7.86

u/ml

0.22

Any mental disorder

3353

11102

1.54

101.52

1.1

9.61

10.48

u/ml

0.04

171

Other special examinations and investigations of persons without complaint or reported diagnosis

2052

6090

1.74

101.21

1.1

13.81

8.09

u/ml

0.23

Asthma, including avohilmo

3549

13953

1.50

99.49

1.1

14.47

8.77

u/ml

0.28

204

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3356

12810

1.52

98.75

1.1

2.37

12.09

u/ml

1.90

205

Psychiatric diseases

3289

10946

1.53

97.31

1.1

10.53

10.59

u/ml

0.00

169

Gingivitis and periodontal diseases

2624

8603

1.60

95.69

1.1

14.86

6.54

u/ml

0.30

139

Disorders of thyroid, IBD co-morbidities

606

1736

2.63

94.97

1.1

2.80

9.66

u/ml

0.75

Intestinal infectious diseases

2797

14323

1.55

94.71

1.1

18.74

8.76

u/ml

0.42

218

Episodal and paroxysmal disorders

3472

12048

1.50

94.44

1.1

6.76

13.18

u/ml

0.45

168

Dorsopathies

3193

10865

1.52

93.49

1.1

12.36

7.54

u/ml

0.26

159

Autoimmune diseases related-to ILD

2471

14016

1.58

93.48

1.1

22.27

7.76

u/ml

0.79

209

Medical observation and evaluation for suspected diseases and conditions

1996

6090

1.71

93.36

1.1

16.00

8.09

u/ml

0.34

Neurological diseases

2853

9353

1.56

92.94

1.1

13.40

12.84

u/ml

0.02

130

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1240

3197

1.99

92.55

1.1

1.03

15.01

u/ml

1.01

Asthma (only as main-diagnosis), excluding more controls

2176

8026

1.65

91.17

1.1

22.36

4.66

u/ml

0.67

134

Abnormalities of breathing

2731

10602

1.56

90.84

1.1

19.52

9.80

u/ml

0.49

163

Asthma (only as main-diagnosis)

2199

8255

1.64

90.52

1.1

22.36

4.62

u/ml

0.68

138

Nerve, nerve root and plexus disorders

2922

12238

1.52

89.40

1.1

12.25

8.39

u/ml

0.20

180

Exposure to unspecified factor

2847

14775

1.52

89.20

1.1

26.58

7.69

u/ml

0.61

236

Shoulder lesions

2039

7683

1.65

87.87

1.1

2.00

9.99

u/ml

1.28

125

Opioids

3007

10554

1.52

87.51

1.1

9.69

8.51

u/ml

0.05

177

Chronic rhinitis, nasopharyngitis and pharyngitis

1012

5258

1.99

86.12

1.1

2.29

8.94

u/ml

—

Migraine

1680

8591

1.71

85.16

1.1

1.15

12.37

u/ml

1.65

125

Symptoms and signs involving cognition, perception, emotional state and behaviour

2705

12625

1.53

85.02

1.1

10.85

6.70

u/ml

0.19

197

Asthma (diagnoses ohter than nonallergic)

2547

14437

1.53

84.72

1.1

20.88

8.28

u/ml

0.47

218

Sciatica+with lumbago

1390

7584

1.78

84.04

1.1

13.91

5.55

u/ml

0.31

112

Benign neoplasm of colon, rectum, anus and anal canal

1484

7822

1.75

83.98

1.1

3.45

6.69

u/ml

0.38

120

Diseases of oral cavity, salivary glands and jaws

2608

8748

1.55

83.63

1.1

10.72

6.54

u/ml

0.20

139

Other and unspecified iron deficiency

935

4778

2.02

83.36

1.1

2.16

2.27

u/ml

0.04

Other and unspecified anaemias

1018

5171

1.95

82.91

1.1

9.12

9.01

u/ml

0.00

Symptoms and signs involving the skin and subcutaneous tissue

1947

12242

1.61

82.31

1.1

12.19

5.55

u/ml

0.30

171

Other anaemias

1024

5226

1.94

81.52

1.1

9.12

8.91

u/ml

0.01

Benign neoplasm of colon, rectum, anus and anal canal

1427

5885

1.77

80.89

1.1

3.21

8.68

u/ml

0.52

GASTRO-related operations

2668

8863

1.53

80.56

1.1

14.70

11.85

u/ml

0.11

122

Any gastric operation

2668

8863

1.53

80.56

1.1

14.70

11.85

u/ml

0.11

122

Asthma, unspecified (mode), excluding more controls

1523

7086

1.72

79.94

1.1

3.80

4.79

u/ml

0.15

119

Diseases of the skin and subcutaneous tissue

3067

10497

1.49

79.83

1.1

22.36

9.47

u/ml

0.52

152

Disorders of adult personality and behaviour

977

5158

1.96

79.50

1.1

1.30

7.92

u/ml

0.69

Other/unspecified dorsalgia

1073

5792

1.89

79.46

1.1

2.75

5.23

u/ml

0.34

Lumbar disc prolapse

1694

8222

1.67

79.23

1.1

2.01

5.21

u/ml

0.71

121

Chronic gastritis

738

3527

2.16

79.05

1.1

5.47

1.90

u/ml

0.46

Diaphragmatic hernia

959

5053

1.95

78.05

1.1

1.36

9.58

u/ml

0.90

Personality disorders

924

4831

1.98

77.47

1.1

1.26

8.28

u/ml

0.67

Aplastic and other anaemias

1091

5674

1.87

77.27

1.1

8.54

8.37

u/ml

0.01

Other and unspecified polyneuropathies, also in other diseases

504

2077

2.53

77.26

1.1

32.64

1.19

u/ml

—

Asthma, unspecified (mode)

1532

7284

1.70

76.94

1.1

3.80

4.78

u/ml

0.15

122

Disturbances of skin sensation

871

4476

2.01

76.81

1.1

28.14

2.35

u/ml

0.54

Hypothyroidism, strict autoimmune

2073

8804

1.59

76.55

1.1

9.15

5.31

u/ml

0.23

113

Functional dyspepsia

804

4023

2.07

76.36

1.1

4.60

7.73

u/ml

0.19

Spondylopathies

2002

7711

1.60

76.16

1.1

13.02

5.16

u/ml

0.42

116

Parasetamol

2459

8277

1.54

75.83

1.1

12.00

7.35

u/ml

0.18

114

Follow-up examination after treatment for conditions other than malignant neoplasms

1331

5000

1.78

75.78

1.1

1.27

4.25

u/ml

0.97

Persons encountering health services for specific procedures and health care

3131

13563

1.45

75.08

1.1

19.37

8.57

u/ml

0.45

216

Other noninfective gastroenteritis and colitis

794

3981

2.07

75.01

1.1

6.86

8.86

u/ml

0.10

Diarrhoea and gastroenteritis of presumed infectious origin

2033

12019

1.56

74.46

1.1

23.31

9.63

u/ml

0.47

181

Diseases of the eye and adnexa

2632

8856

1.51

74.20

1.1

12.69

9.43

u/ml

0.11

137

Complications of medical and surgical care

1944

11918

1.58

74.16

1.1

22.46

4.05

u/ml

0.73

184

Statin medication

1978

7041

1.60

73.85

1.1

15.53

6.42

u/ml

0.36

117

Nutritional anaemias

1266

7175

1.76

73.40

1.1

2.09

7.70

u/ml

0.76

100

Persons encountering health services in other circumstances, wide

3481

12846

1.42

73.35

1.1

2.47

12.03

u/ml

1.88

206

Specific personality disorders

814

4161

2.03

73.06

1.1

1.03

9.39

u/ml

0.70

Dental pulpitis 1, only avohilmo

3263

12001

1.44

72.74

1.1

4.63

11.62

u/ml

0.90

200

Dental pulpitis 4, only avohilmo

3256

11969

1.44

72.73

1.1

2.27

11.67

u/ml

1.75

199

Malaise and fatigue

1330

6521

1.74

72.48

1.1

2.56

9.98

u/ml

0.78

Diseases of liver

906

4834

1.93

71.06

1.1

4.68

10.03

u/ml

—

Diseases of pulp and periapical tissues, including avohilmo

3201

11731

1.44

70.66

1.1

2.42

11.79

u/ml

1.70

197

Diseases of the musculoskeletal system and connective tissue

1823

5728

1.62

70.23

1.1

2.38

11.64

u/ml

1.06

Dental pulpitis 4

3202

11750

1.43

70.14

1.1

2.35

11.84

u/ml

1.73

196

Certain infectious and parasitic diseases

3058

10714

1.45

70.10

1.1

24.29

5.34

u/ml

0.90

165

Dental pulpitis 1

3200

11753

1.43

69.84

1.1

2.38

11.79

u/ml

1.72

197

Disorders of eyelid, lacrimal system and orbit

2251

11868

1.51

69.13

1.1

11.28

11.60

u/ml

0.01

172

Polyarthropathies

1853

7923

1.58

68.53

1.1

11.18

12.39

u/ml

0.05

107

Iron deficiency anaemia

1091

6164

1.80

68.45

1.1

1.91

8.41

u/ml

0.81

Polyneuropathies and other disorders of the peripheral nervous system

559

2543

2.28

68.18

1.1

29.44

1.14

u/ml

—

Nonorganic sleeping disorders, excluding more controls

581

2688

2.24

68.14

1.1

37.32

1.47

u/ml

—

Persons encountering health services for examination and investigation

1904

6090

1.59

67.70

1.1

15.40

8.09

u/ml

0.23

Asthma-related infections

1630

10185

1.60

67.35

1.1

30.34

7.78

u/ml

0.59

142

Asthma, hospital admission 2, infections

1630

10185

1.60

67.35

1.1

30.34

7.78

u/ml

0.59

142

Falls/tendency to fall

3330

11957

1.41

66.52

1.1

11.63

10.78

u/ml

0.03

194

Osteopathies and chondropathies

1471

8667

1.64

66.47

1.1

1.36

10.14

u/ml

1.30

120

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

851

4548

1.92

66.41

1.1

1.19

11.09

u/ml

—

Disorders of the thyroid gland

2683

12222

1.46

66.31

1.1

7.36

9.13

u/ml

0.12

177

Other arthrosis

1293

5494

1.72

66.09

1.1

1.23

14.77

u/ml

1.56

Chronic lower respiratory diseases

3508

13790

1.39

65.76

1.1

20.47

7.31

u/ml

0.65

209

Spondylosis

1267

6484

1.71

65.73

1.1

4.13

5.29

u/ml

0.13

103

Visual disturbances

1314

7989

1.68

65.47

1.1

40.40

7.29

u/ml

0.63

115

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1579

9988

1.60

65.45

1.1

28.28

3.79

u/ml

0.78

158

Generalized anxiety disorder

564

2636

2.23

64.83

1.1

14.79

3.50

u/ml

—

Behavioural syndromes associated with physiological disturbances and physical factors

1056

6088

1.78

64.35

1.1

18.24

6.42

u/ml

0.30

1309

7920

1.68

64.28

1.1

37.56

9.57

u/ml

0.57

110

Inflammatory bowel disease treatment related agents

3273

13433

1.40

64.20

1.1

22.71

7.65

u/ml

0.68

208

ILD medications

3299

13096

1.40

63.91

1.1

22.40

7.58

u/ml

0.74

196

Noninfective enteritis and colitis

1343

8252

1.66

63.78

1.1

18.02

7.68

u/ml

0.39

109

Other diseases of upper respiratory tract

3168

11850

1.41

63.69

1.1

3.11

8.77

u/ml

1.01

198

Hypertension, essential

2069

7839

1.53

63.53

1.1

7.68

3.16

u/ml

0.56

126

Abnormal findings on examination of blood, without diagnosis

1082

5869

1.76

63.47

1.1

26.57

13.13

u/ml

0.31

Benign neoplasm: Colon

1197

7002

1.71

63.36

1.1

3.54

7.21

u/ml

0.39

106

Dental caries 3 and operation codes

2462

8655

1.48

63.29

1.1

1.88

11.49

u/ml

1.55

142

Other diseases of urinary system

2909

11628

1.43

62.88

1.1

10.70

10.12

u/ml

0.02

178

Cystitis

2487

10534

1.47

62.79

1.1

11.73

10.23

u/ml

0.05

165

ILD medications: immunosuppressive drugs

1750

10996

1.55

62.78

1.1

22.12

8.24

u/ml

0.55

160

Other disorders of urethra and urinary system

1939

9676

1.53

61.98

1.1

12.70

5.75

u/ml

0.26

150

Dental caries 1 and operation codes

2298

8003

1.49

61.86

1.1

1.87

9.64

u/ml

1.33

132

Hypothyroidism, other/unspecified

2524

11643

1.45

61.72

1.1

7.94

9.03

u/ml

0.07

171

Visual disturbances and blindness

1374

8579

1.64

61.45

1.1

38.44

7.08

u/ml

0.63

121

Benign neoplasm: Colon

1184

5405

1.71

60.88

1.1

3.28

9.14

u/ml

0.51

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1462

9306

1.60

59.95

1.1

15.45

6.30

u/ml

0.38

139

Other joint disorders

2650

9936

1.44

59.63

1.1

7.01

15.53

u/ml

0.64

141

Hypothyreosis and Thyroxine purchase for inclusion criteria

2593

12099

1.43

59.49

1.1

7.94

8.63

u/ml

0.04

180

Complications of surgical and medical care, not elsewhere classified

2570

13078

1.43

58.48

1.1

16.81

7.66

u/ml

0.42

199

Infections, IBD-co-morbidities

423

1295

2.45

57.67

1.1

66.38

5.54

u/ml

—

Subjective visual disturbances

713

3776

1.95

57.67

1.1

49.88

2.48

u/ml

—

Fall on same level

3312

13637

1.37

57.36

1.1

13.61

10.13

u/ml

0.16

212

Dental operations

1592

5214

1.59

56.91

1.1

1.18

9.59

u/ml

0.99

Use of hypnotics and sedatives

2811

11691

1.41

56.87

1.1

1.25

11.35

u/ml

2.07

183

Asthma, hospital admissions , main diagnosis only

2311

14626

1.44

55.75

1.1

21.36

8.11

u/ml

0.48

216

Other systemic involvement of connective tissue (FG)

722

3852

1.91

55.61

1.1

1.47

2.41

u/ml

0.53

Other pulmonary diagnosis

2384

8335

1.45

55.48

1.1

12.94

4.58

u/ml

0.37

140

ILD medications: prednisolone, methylprednisolone, prednisone

3061

12666

1.38

55.33

1.1

25.56

7.68

u/ml

0.80

193

Finngen Rheumatological endpoints

2732

11198

1.41

55.29

1.1

5.83

13.76

u/ml

0.73

168

Rotator cuff syndrome

1450

6897

1.59

55.23

1.1

1.89

10.22

u/ml

1.21

115

Atopic dermatitis

1725

9854

1.52

55.17

1.1

3.00

13.28

u/ml

1.37

139

Myalgia

661

3463

1.97

55.08

1.1

1.80

13.07

u/ml

0.88

Other external causes of accidental injury

2490

8798

1.44

54.70

1.1

14.98

8.01

u/ml

0.27

152

Cardiac arrhythmias

1751

7714

1.52

54.56

1.1

17.55

8.59

u/ml

0.32

117

Phobic anxiety disorders

488

2307

2.21

54.54

1.1

15.08

3.36

u/ml

—

Oral corticosteroids

2858

12590

1.39

54.24

1.1

25.04

6.03

u/ml

0.82

198

ILD differential diagnosis

2365

8291

1.45

54.22

1.1

13.33

4.60

u/ml

0.37

139

Special screening examination for infectious and parasitic diseases

770

3128

1.88

54.10

1.1

4.97

3.34

u/ml

—

COPD differential diagnosis

2364

8295

1.45

53.95

1.1

13.33

4.60

u/ml

0.37

139

Dental operations, only avohilmo

1662

5562

1.55

53.64

1.1

1.84

9.85

u/ml

1.02

Dermatitis

1573

10434

1.53

53.64

1.1

9.80

6.79

u/ml

0.14

145

Chronic sinusitis

1154

7135

1.65

53.61

1.1

51.02

8.21

u/ml

—

118

Excluding asthma or asthma-COPD overlap

2371

8335

1.44

53.59

1.1

13.33

4.58

u/ml

0.38

140

Dizziness and giddiness

1893

10520

1.48

53.42

1.1

16.76

6.52

u/ml

0.32

164

Other and unspecified dermatitis

1339

8614

1.58

52.70

1.1

11.45

5.10

u/ml

0.28

120

Symptoms and signs concerning food and fluid intake

338

1392

2.54

52.30

1.1

1.02

27.08

u/ml

—

Type 2 diabetes, wide definition

1908

8502

1.48

52.22

1.1

16.74

4.61

u/ml

0.50

145

Dysphagia

586

3000

2.01

52.09

1.1

7.58

6.53

u/ml

0.05

Complications of procedures, not elsewhere classified

2063

12494

1.45

51.89

1.1

10.45

7.67

u/ml

0.14

194

Nausea and vomiting

726

3928

1.86

51.63

1.1

2.48

13.54

u/ml

0.77

Arthropathies

2717

10011

1.40

51.63

1.1

9.64

15.53

u/ml

0.36

141

Hypertensive diseases (excluding secondary)

1545

5867

1.56

51.63

1.1

24.21

4.19

u/ml

0.60

First line medication for Crohn's disease

3169

12871

1.36

51.18

1.1

24.57

7.59

u/ml

0.79

196

Other reaction to severe stress, and adjustment disorders

1084

6701

1.65

50.71

1.1

36.32

8.22

u/ml

0.47

107

Dental caries

695

3760

1.88

50.67

1.1

15.12

7.74

u/ml

—

Cervicobrachial syndrome

608

3187

1.96

50.57

1.1

0.94

3.27

u/ml

1.59

Osteoporosis

633

3200

1.94

50.53

1.1

0.86

1.80

u/ml

1.37

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

769

3949

1.84

50.41

1.1

5.46

18.85

u/ml

—

Disorders of synovium and tendon

1376

8072

1.56

50.33

1.1

9.85

9.86

u/ml

0.00

127

Cough

1097

6538

1.64

49.86

1.1

14.72

8.48

u/ml

0.21

Temporomandibular joint disorders

466

2234

2.15

49.84

1.1

41.63

2.88

u/ml

—

Dental caries 2 and operation codes

2191

12407

1.42

49.72

1.1

7.90

10.62

u/ml

0.16

185

Accidents

2453

8798

1.41

49.57

1.1

14.54

8.01

u/ml

0.26

152

Acute upper respiratory infections

2868

13298

1.37

49.49

1.1

9.04

6.94

u/ml

0.13

199

Type 2 diabetes

2497

10714

1.40

49.46

1.1

22.19

5.06

u/ml

0.74

174

Collagenous colitis

290

1152

2.66

48.80

1.1

17.30

1.78

u/ml

—

Dental pulpitis 2, only avohilmo

1826

6391

1.48

47.51

1.1

1.87

10.20

u/ml

1.18

111

Dental caries 1, only avohilmo

2030

7252

1.45

47.28

1.1

2.03

10.39

u/ml

1.30

121

Systemic connective tissue disorders

927

5611

1.69

47.24

1.1

1.41

2.04

u/ml

0.47

Nonalcoholic fatty liver disease

301

1236

2.56

47.21

1.1

—

0.93

—

Dental caries 2

2209

12498

1.41

47.19

1.1

8.10

10.63

u/ml

0.15

185

Spinal stenosis

1077

5244

1.64

47.14

1.1

6.84

4.66

u/ml

0.18

Dental pulpitis 2

1799

6292

1.48

47.11

1.1

1.87

10.29

u/ml

1.18

110

KRA_PSY_EATING, excluding more controls

345

1504

2.40

47.00

1.1

0.89

1.79

u/ml

—

Antihypertensive medication - note that there are other indications

2027

7783

1.45

47.00

1.1

15.47

13.54

u/ml

0.06

105

Abnormalities of heart beat

903

5381

1.70

46.92

1.1

1.45

5.23

u/ml

0.62

Disorders of lacrimal system

1075

6763

1.62

46.80

1.1

18.08

7.97

u/ml

0.25

Dental caries 3, only avohilmo

2195

7972

1.42

46.71

1.1

2.02

12.09

u/ml

1.52

134

Migraine with aura

773

4477

1.78

46.64

1.1

0.94

6.89

u/ml

0.97

Symptoms and signs involving the nervous and musculoskeletal systems

1474

9945

1.51

46.33

1.1

2.43

6.61

u/ml

0.70

132

Dental caries 1

1986

7092

1.45

46.23

1.1

2.05

10.39

u/ml

1.30

121

Dentinal caries

609

3274

1.90

46.11

1.1

13.14

9.14

u/ml

—

Other disorders of lacrimal gland

893

5389

1.70

46.10

1.1

22.13

6.13

u/ml

0.34

Voice disturbances

709

4025

1.81

45.82

1.1

1.05

1.72

u/ml

1.07

Nonorganic sleeping disorders

581

3107

1.93

45.81

1.1

37.32

3.00

u/ml

—

Dental caries 3

2153

7818

1.42

45.75

1.1

2.02

12.17

u/ml

1.52

133

Genitourinary diseases

1720

5873

1.49

45.57

1.1

28.18

15.48

u/ml

0.31

Post-traumatic stress disorder

320

1377

2.45

45.34

1.1

7.96

3.42

u/ml

—

Other disorders of skin and subcutaneous tissue

1640

10381

1.47

45.07

1.1

20.80

2.20

u/ml

0.73

156

Dental caries, including avohilmo

1977

7091

1.44

45.00

1.1

2.05

10.39

u/ml

1.30

121

Somatoform disorder

487

2472

2.04

44.84

1.1

0.93

3.44

u/ml

1.09

Symptoms and signs involving speech and voice

833

4972

1.71

44.82

1.1

1.12

2.18

u/ml

1.10

Pain and other conditions associated with female genital organs and menstrual cycle

686

3721

1.82

44.78

1.1

2.09

11.57

u/ml

—

Sleep disorders

630

3481

1.86

44.68

1.1

30.81

2.76

u/ml

0.44

Hypertension

2066

8312

1.42

44.68

1.1

16.33

3.11

u/ml

0.68

129

Disorders of conjunctiva

2291

14043

1.38

44.63

1.1

11.14

10.37

u/ml

0.03

214

Other systemic involvement of connective tissue

734

4241

1.78

44.57

1.1

1.47

2.25

u/ml

0.49

Hypertensive diseases

2066

8325

1.42

44.34

1.1

16.33

3.11

u/ml

0.68

129

3131

12545

1.33

44.31

1.1

8.16

7.27

u/ml

0.05

182

Irregular menses

1515

8384

1.50

44.21

1.1

9.51

6.88

u/ml

0.17

136

Bipolar affective disorders

561

3003

1.92

43.97

1.1

0.87

1.69

u/ml

—

Benzodiazepine use

2585

13719

1.36

43.42

1.1

8.66

9.31

u/ml

0.03

212

Diseases of pulp and periapical tissues

828

4974

1.70

43.24

1.1

10.60

9.76

u/ml

—

Noninfectious colitis NAS

407

1970

2.14

42.84

1.2

1.1

1.10

1.50

u/ml

—

Dentofacial anomalies [including malocclusion]

799

4723

1.71

42.76

1.1

22.65

2.83

u/ml

0.42

Asthma/COPD (KELA code 203)

2600

13717

1.35

42.58

1.1

12.14

7.34

u/ml

0.20

208

Unspecified mental disorder

1107

7170

1.57

42.41

1.1

1.34

8.01

u/ml

1.02

103

Allergic asthma (mode), excluding more controls

763

4431

1.73

42.34

1.2

1.1

47.07

2.30

u/ml

0.77

Emotionally unstable personality disorder

440

2206

2.08

42.27

1.1

0.99

4.12

u/ml

—

Sleep disorders (combined)

2536

12394

1.36

42.13

1.1

11.44

6.98

u/ml

0.18

193

Dental caries 2, only avohilmo

2150

12393

1.39

42.05

1.1

17.02

9.36

u/ml

0.28

183

Injuries to the ankle and foot

1924

12621

1.41

42.02

1.1

11.79

11.72

u/ml

0.00

191

Other symptoms and signs involving cognitive functions and awareness

972

5734

1.62

41.79

1.1

1.21

4.92

u/ml

0.77

Cardiovascular diseases

2032

7943

1.41

41.65

1.1

26.06

9.67

u/ml

0.52

102

External causes of morbidity and mortality

2016

7210

1.42

41.63

1.1

4.19

7.75

u/ml

0.49

129

Persistent mood disorders

534

2863

1.92

41.62

1.1

1.28

1.72

u/ml

—

Allergic asthma (mode)

763

4453

1.72

41.60

1.2

1.1

47.07

2.28

u/ml

0.77

Pain, not elsewhere classified

725

4255

1.74

41.53

1.1

2.95

2.53

u/ml

0.07

Dyspnoea

2209

12439

1.38

41.26

1.1

15.49

6.24

u/ml

0.53

179

Other retinal disorders

1402

7654

1.49

41.20

1.1

7.09

7.04

u/ml

0.00

121

Other arrhythmias

1663

8928

1.45

41.19

1.1

13.35

6.17

u/ml

0.26

124

Conjunctivitis

2111

13521

1.38

40.45

1.1

12.11

9.40

u/ml

0.09

202

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

921

5737

1.63

40.23

1.1

11.83

9.50

u/ml

—

Parodontitis and operation codes

2037

11558

1.39

39.95

1.1

2.97

8.67

u/ml

1.10

182

Other nutritional deficiencies

1713

11947

1.42

39.90

1.1

2.57

11.64

u/ml

1.61

182

Disorders of choroid and retina

1812

9433

1.42

39.80

1.1

6.44

8.08

u/ml

0.10

155

Migraine without aura

663

3857

1.77

39.58

1.1

1.21

15.51

u/ml

—

Reimbursement for rheumatic diseases

1488

10364

1.45

39.35

1.1

8.07

9.40

u/ml

0.06

144

Abnormal serum enzyme levels

583

3222

1.82

39.15

1.1

35.43

13.19

u/ml

—

Other specified/unspecified arthritis

686

4036

1.74

38.97

1.1

0.93

12.86

u/ml

1.06

Factors influencing health status and contact with health services

815

2434

1.70

38.38

1.1

0.90

5.42

u/ml

—

Temporomandibular joint disorders, including avohilmo

1240

8413

1.50

38.10

1.1

20.25

7.73

u/ml

0.28

136

Insomnia

470

2501

1.94

37.77

1.1

47.71

3.43

u/ml

—

Pain in thoracic spine

414

2115

2.02

37.42

1.1

1.04

3.59

u/ml

—

COPD/asthma/ILD related infections

2951

11374

1.31

37.39

1.1

12.36

6.66

u/ml

0.37

166

COPD/asthma related infections

2951

11374

1.31

37.39

1.1

12.36

6.66

u/ml

0.37

166

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1239

8271

1.49

36.95

1.1

1.20

9.10

u/ml

1.51

139

Schizophrenia or delusion, excluding more controls

758

4604

1.66

36.87

1.1

1.16

5.59

u/ml

0.69

Cervical disc disorders

813

5090

1.62

36.09

1.1

24.20

5.25

u/ml

0.36

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

851

5399

1.61

36.04

1.1

1.19

10.26

u/ml

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

2244

11492

1.35

35.99

1.1

8.63

8.81

u/ml

0.01

166

Disorders of other endocrine glands

1172

7835

1.50

35.84

1.1

1.67

11.71

u/ml

1.22

101

Soft tissue disorders related to use, overuse and pressure

618

3624

1.74

35.55

1.1

0.93

10.63

u/ml

0.95

L04AX Other immunosuppressants

1419

10011

1.44

35.48

1.1

9.91

8.96

u/ml

0.04

138

Deforming dorsopathies

726

4447

1.67

35.44

1.1

14.29

6.56

u/ml

0.31

Other arthritis (FG)

778

4849

1.64

35.36

1.1

0.93

10.86

u/ml

1.04

Non-selective monoamine reuptake inhibitors

896

5590

1.58

35.29

1.1

1.15

9.42

u/ml

0.90

Second line medication for Crohn's disease

1457

10345

1.43

35.14

1.1

11.02

8.79

u/ml

0.10

140

Other gastritis (incl. Duodenitis)

517

2896

1.83

34.94

1.1

2.44

9.83

u/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2069

11223

1.35

34.76

1.1

13.61

8.03

u/ml

0.23

164

Substance abuse, excluding more controls

1240

7463

1.47

34.73

1.1

22.97

6.98

u/ml

0.47

109

Benign neoplasms

2625

11249

1.32

34.68

1.1

11.80

10.67

u/ml

0.05

164

Parodontitis or operation codes

2122

11725

1.35

34.62

1.1

2.97

8.34

u/ml

1.07

190

Obesity related asthma

800

5053

1.61

34.43

1.1

28.18

5.49

u/ml

0.37

Mixed and other personality disorders

265

1184

2.34

34.43

1.1

1.90

0.86

u/ml

—

Parodontitis

2118

11723

1.35

34.35

1.1

2.97

8.34

u/ml

1.07

190

Heartburn

280

1278

2.27

34.29

1.1

0.92

1.71

u/ml

—

Disorders of skin appendages

1280

8927

1.46

34.13

1.1

16.64

10.90

u/ml

0.23

131

Obesity, other/unspecified

892

5801

1.57

33.84

1.1

1.89

9.27

u/ml

0.88

Rheumatoid arthritis

760

4311

1.63

33.81

1.1

15.14

10.97

u/ml

0.10

Other heart diseases, wide

2495

11883

1.32

33.65

1.1

16.55

8.50

u/ml

0.41

159

Acute upper respiratory infections of multiple and unspecified sites

1980

11075

1.35

33.54

1.1

25.54

7.19

u/ml

0.58

160

Oedema, not elsewhere classified

705

4322

1.65

33.46

1.1

1.38

7.10

u/ml

0.73

Diseases of the respiratory system

1869

6854

1.38

33.41

1.1

3.61

5.08

u/ml

0.20

116

Chronic diseases of tonsils and adenoids

2209

10573

1.34

33.40

1.1

10.11

10.26

u/ml

0.01

165

Chronic periodontitis, including avohilmo

2100

11724

1.34

32.98

1.1

2.97

8.38

u/ml

1.07

189

Excessive, frequent and irregular menstruation

1247

4765

1.48

32.95

1.1

7.67

8.99

u/ml

0.06

Weight loss

276

1281

2.25

32.65

1.1

1.08

1.44

u/ml

—

Haemorrhage from respiratory passages

717

4131

1.64

32.58

1.1

2.24

11.26

u/ml

—

Other and unspecified nerve root and plexus disorders, also in other diseases

460

2552

1.85

32.28

1.1

7.74

2.12

u/ml

—

Obsessive-compulsive disorder

243

1079

2.36

32.18

1.1

1.38

4.02

u/ml

—

Haemorrhoids and perianal venous thrombosis

609

3663

1.69

31.72

1.1

2.72

11.73

u/ml

0.65

Coxibs

722

2346

1.66

31.63

1.1

18.89

6.47

u/ml

0.29

Other diseases of lip and oral mucosa

383

2021

1.95

31.49

1.1

1.07

10.62

u/ml

—

Asthma and allergy, excluding more controls

449

2464

1.85

31.46

1.2

1.1

49.89

1.68

u/ml

—

Asthma and allergy

449

2469

1.85

31.26

1.2

1.1

49.89

1.97

u/ml

—

Cardiovascular diseases (excluding rheumatic etc)

1975

8552

1.35

31.23

1.1

15.82

12.78

u/ml

0.10

112

Carpal tunnel syndrome

1419

9228

1.41

31.02

1.1

16.77

6.90

u/ml

0.42

138

Disorders of gallbladder, biliary tract and pancreas

2347

11654

1.31

30.99

1.1

8.79

7.61

u/ml

0.06

174

Poisoning by drugs, medicaments and biological substances

675

4207

1.64

30.93

1.1

1.22

8.79

u/ml

—

Provisional assignment of new diseases of uncertain etiology

1150

8021

1.46

30.77

1.1

32.23

6.33

u/ml

0.65

108

Atopic dermatitis, strict definition with reimbursement

931

6051

1.52

30.63

1.1

1.12

14.18

u/ml

1.35

Codes for special purposes

1150

8030

1.45

30.59

1.1

32.23

6.33

u/ml

0.65

108

Covid-19 confirmed case

689

4326

1.63

30.50

1.1

80.61

2.39

u/ml

—

Rheumatism, unspecified

383

2048

1.93

30.40

1.1

1.51

2.13

u/ml

—

Bronchitis

2765

14311

1.28

30.35

1.1

18.48

6.70

u/ml

0.53

216

Syncope and collapse

1005

6044

1.49

30.35

1.1

1.94

6.34

u/ml

0.75

Cervicalgia

494

2852

1.77

30.22

1.1

1.38

2.62

u/ml

—

Papulosquamous disorders

922

6187

1.52

30.16

1.1

20.31

8.35

u/ml

0.40

Other enthesopathies

712

4516

1.61

30.12

1.1

1.34

11.45

u/ml

1.19

Asthma-related pneumonia

797

5179

1.56

30.06

1.1

35.49

9.85

u/ml

—

Fever of other and unknown origin

1296

8573

1.42

30.05

1.1

13.77

10.20

u/ml

0.11

116

Asthma-related pneumonia or sepsis

799

5205

1.56

29.80

1.1

35.49

9.85

u/ml

—

Asthma, hospital admissions 3, pneumonia

799

5205

1.56

29.80

1.1

35.49

9.85

u/ml

—

Poisoning by medicine

611

3752

1.67

29.79

1.1

1.22

10.03

u/ml

—

Infections of the skin and subcutaneous tissue

1413

10224

1.39

29.75

1.1

15.64

10.92

u/ml

0.19

143

Ovarian cyst

1103

4375

1.48

29.69

1.1

1.44

9.11

u/ml

0.59

Arthrosis

1629

6558

1.38

29.57

1.1

1.18

13.57

u/ml

1.69

Hernia

2252

11796

1.31

29.55

1.1

1.45

8.79

u/ml

1.82

181

Benign neoplasms

2173

9415

1.32

29.47

1.1

13.75

11.20

u/ml

0.10

131

Need for other prophylactic measures

182

744

2.58

29.16

1.1

—

1.75

—

Disorders of psychological development

449

2374

1.82

28.83

1.1

1.30

18.99

u/ml

—

Other obstetric conditions, not elsewhere classified

1047

4676

1.48

28.65

1.1

4.66

12.18

u/ml

0.50

Kela-code for severe mental illness

917

6213

1.50

28.61

1.1

1.28

9.10

u/ml

1.04

Diseases of the ear and mastoid process

3173

12903

1.25

28.53

1.1

14.50

7.46

u/ml

0.39

185

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1029

4582

1.49

28.49

1.1

4.88

12.34

u/ml

0.48

Disorders of vitreous body and globe

1074

7328

1.45

28.18

1.1

7.58

3.85

u/ml

0.26

114

Excessive attrition of teeth

1114

4188

1.47

28.14

1.1

0.99

6.79

u/ml

0.82

Gonarthrosis

1398

5787

1.40

28.02

1.1

1.85

14.61

u/ml

1.44

Exposure to other specified factors

1860

13313

1.32

28.00

1.1

2.78

10.09

u/ml

1.50

207

Implicit Sepsis

1663

9673

1.35

27.99

1.1

16.53

8.88

u/ml

0.27

145

Sleep apnoea, including avohilmo

2277

11507

1.30

27.85

1.1

11.71

6.17

u/ml

0.22

179

Gonarthrosis [arthrosis of knee](FG)

1649

7218

1.36

27.54

1.1

1.73

11.44

u/ml

1.43

110

Unspecified fall

1162

8217

1.42

27.53

1.1

7.48

9.86

u/ml

0.18

119

Atopic dermatitis, strict definition

916

6138

1.49

27.48

1.1

1.12

14.68

u/ml

1.40

Convulsions, not elsewhere classified

603

3721

1.63

27.21

1.1

1.29

19.86

u/ml

1.00

Disorders of vitreous body

1043

7157

1.45

27.12

1.1

7.58

3.93

u/ml

0.25

111

Endometriosis

1015

4155

1.48

27.06

1.1

2.40

9.92

u/ml

—

General examination and investigation of persons without complaint and reported diagnosis

1552

6085

1.37

27.03

1.1

11.22

8.09

u/ml

0.13

Injuries to the thorax

930

6392

1.47

26.86

1.1

1.57

8.71

u/ml

0.97

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

843

5697

1.51

26.82

1.1

1.18

6.06

u/ml

0.67

Eating disorder

348

1887

1.92

26.80

1.1

0.89

5.02

u/ml

—

Other (not insulin) diabetes medications

2209

10372

1.29

26.65

1.1

20.25

5.13

u/ml

0.59

171

Trochanteric bursitis

339

1820

1.92

26.61

1.1

0.98

2.30

u/ml

—

Inflammatory diseases of female pelvic organs

1742

9973

1.33

26.59

1.1

1.03

7.35

u/ml

1.40

165

Concussion

1246

7796

1.40

26.57

1.1

2.22

5.52

u/ml

1.03

105

Migraine with aura and triptan purchases

479

2853

1.73

26.54

1.1

1.24

3.38

u/ml

—

Thyroiditis, ILD-related definition

344

1862

1.91

26.49

1.2

1.1

9.68

2.01

u/ml

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1478

10836

1.36

26.48

1.1

1.25

9.14

u/ml

1.59

171

Sicca syndrome [Sjögren]

256

1258

2.12

26.26

1.1

1.70

0.95

u/ml

—

Acute sinusitis

1348

9241

1.38

26.23

1.1

23.58

8.20

u/ml

0.38

137

Adhesive capsulitis of shoulder

383

2143

1.83

26.20

1.1

1.12

8.51

u/ml

—

Diabetic retinopathy, strict definition

450

2312

1.76

26.13

1.2

1.1

20.76

17.41

u/ml

—

Polycystic ovarian syndrome, consortium definition

2085

9775

1.30

25.91

1.1

8.26

6.17

u/ml

0.15

155

Meniscus derangement

1215

5978

1.41

25.80

1.1

1.10

14.29

u/ml

1.58

Symptoms and signs involving the urinary system

1704

10011

1.33

25.76

1.1

15.53

6.85

u/ml

0.34

146

Cholecystectomy

1599

10699

1.34

25.42

1.1

1.52

6.34

u/ml

1.17

164

Postprocedural endocrine and metabolic disorders, not elsewhere classified

331

1797

1.90

25.21

1.1

1.26

2.24

u/ml

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

2138

11347

1.29

25.19

1.1

1.15

10.90

u/ml

1.99

171

Triptan medication for migraine, single purchase ok

2138

11347

1.29

25.19

1.1

1.15

10.90

u/ml

1.99

171

Recurring oral aphthae, including avohilmo

375

2117

1.83

25.17

1.1

7.70

2.85

u/ml

—

Non-allergic asthma (mode)

502

3031

1.67

25.17

1.1

0.78

7.50

u/ml

—

Fall on same level involving ice and snow

1345

9975

1.37

25.04

1.1

1.54

6.00

u/ml

0.97

150

Other diseases of anus and rectum

602

3832

1.59

25.01

1.1

1.11

12.00

u/ml

0.96

Non-allergic asthma (mode), excluding more controls

502

3036

1.67

25.00

1.1

0.78

7.50

u/ml

—

Allergic conjunctivitis

1534

11420

1.34

25.00

1.1

1.23

8.50

u/ml

1.61

187

Undetermined asthma, excluding more controls

323

1741

1.90

24.96

1.1

2.74

1.82

u/ml

—

Immunodeficiencies

167

708

2.50

24.86

1.3

1.1

100.47

2.26

u/ml

—

L04AA Selective immunosuppressants

548

3439

1.63

24.57

1.1

63.07

2.76

u/ml

—

Undetermined asthma

323

1750

1.89

24.57

1.1

2.74

1.83

u/ml

—

Suicide or other Intentional self-harm

642

4184

1.56

24.35

1.1

1.20

8.89

u/ml

—

Obesity

1535

11542

1.33

24.35

1.1

1.53

12.20

u/ml

1.99

171

Obesity and other hyperalimentation

1540

11589

1.33

24.16

1.1

1.53

12.13

u/ml

1.99

172

Maternal care for other conditions predominantly related to pregnancy

612

3904

1.58

24.14

1.1

5.19

5.41

u/ml

—

2284

11350

1.27

24.09

1.1

19.06

6.66

u/ml

0.51

166

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2284

11350

1.27

24.09

1.1

19.06

6.66

u/ml

0.51

166

Migraine without aura and triptan purchases

498

3081

1.66

23.83

1.1

1.20

3.84

u/ml

—

Injuries to the knee and lower leg

3064

14359

1.23

23.81

1.1

10.70

9.96

u/ml

0.04

218

Other and unspecified nonorganic psychotic disorders

512

3188

1.64

23.70

1.1

1.25

10.68

u/ml

—

Injury, poisoning and certain other consequences of external causes

1607

6083

1.34

23.61

1.1

3.73

7.03

u/ml

0.44

Other eating disorders

220

1070

2.17

23.56

1.1

0.90

7.27

u/ml

—

Certain disorders involving the immune mechanism

455

2758

1.69

23.46

1.2

1.1

86.26

2.25

u/ml

1.17

Artrosis, including avohilmo

1930

8228

1.30

23.39

1.1

1.06

11.63

u/ml

1.73

114

Diabetes mellitus in pregnancy

971

4439

1.44

23.29

1.1

2.70

6.20

u/ml

—

Other metabolic disorders

352

2000

1.81

23.11

1.1

1.26

2.24

u/ml

—

Other heart diseases

1290

6306

1.37

22.98

1.1

18.40

9.30

u/ml

0.30

Other acute lower respiratory infections

1248

8846

1.36

22.87

1.1

2.82

10.47

u/ml

1.00

118

Spondylolisthesis/Spondylolysis

412

2449

1.72

22.84

1.1

7.78

7.85

u/ml

—

Vasomotor and allergic rhinitis

1028

7311

1.41

22.80

1.1

25.42

9.72

u/ml

0.27

123

Hernia of abdominal wall, postoperative

374

2164

1.76

22.80

1.1

2.53

12.48

u/ml

—

Selective deficiency of immunoglobulin A [IgA]y

7.33

22.79

1.9

1.1

100.47

—

u/ml

—

Neoplasms

2197

9332

1.27

22.72

1.1

20.57

11.62

u/ml

0.33

127

Eating disorders

371

2154

1.78

22.69

1.1

0.89

4.47

u/ml

—

Disorders of sclera, cornea, iris and ciliary body

1255

9353

1.36

22.69

1.1

4.08

11.45

u/ml

0.75

132

Mouth breathing

915

6482

1.43

22.54

1.1

2.07

16.61

u/ml

1.50

Injuries to the abdomen, lower back, lumbar spine and pelvis

865

6028

1.44

22.53

1.1

6.96

9.19

u/ml

0.11

Oter anti-inflammatory and antirheumatic agents, non-steroids

437

1426

1.72

22.34

1.1

1.14

7.33

u/ml

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1228

9073

1.36

22.31

1.1

38.26

8.86

u/ml

0.60

135

Cholelithiasis, broad definition with cholecystitis

1985

10727

1.28

22.30

1.1

1.52

6.77

u/ml

1.30

163

Erosion of teeth, including avohilmo

538

3321

1.60

22.26

1.1

2.34

8.27

u/ml

—

Intracranial trauma

1429

8082

1.33

22.23

1.1

1.99

12.48

u/ml

1.29

110

Alcohol use disorder, Swedish definition

1139

7772

1.37

22.21

1.1

16.62

8.39

u/ml

0.21

109

Benign neoplasm: Colon, unspecified

473

2933

1.64

22.20

1.1

9.11

7.04

u/ml

—

Cholelithiasis

1919

10584

1.28

22.13

1.1

1.56

6.42

u/ml

1.16

161

Other disorders of the musculoskeletal system and connective tissue

330

1864

1.82

22.05

1.1

0.99

1.94

u/ml

—

Disorders of continuity of bone

254

1325

1.98

21.98

1.1

2.57

0.84

u/ml

—

STROKE

1254

6464

1.36

21.92

1.1

44.49

2.66

u/ml

0.81

Other specified/unspecified systemic involvement of connective tissue

179

824

2.27

21.90

1.1

1.80

0.86

u/ml

—

Diseases of salivary glands

436

2664

1.67

21.75

1.1

1.15

2.63

u/ml

—

Sequelae of injuries, of poisoning and of other consequences of external causes

541

3482

1.58

21.73

1.1

1.19

9.48

u/ml

—

Noninflammatory disorders of female genital tract

1325

4967

1.36

21.63

1.1

3.05

8.99

u/ml

0.44

Fracture of foot, except ankle

598

3952

1.54

21.35

1.1

0.93

8.10

u/ml

—

Sequelae of external causes of morbidity and mortality

541

3502

1.57

21.20

1.1

2.16

9.06

u/ml

—

Procreative management

860

5131

1.44

21.11

1.1

2.03

11.78

u/ml

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1308

9175

1.33

21.01

1.1

9.81

6.24

u/ml

0.20

140

Benign neoplasm: Colon, unspecified

473

2965

1.62

20.82

1.1

9.11

7.48

u/ml

—

Other and unspecified effects of external causes

706

4851

1.48

20.80

1.1

37.37

2.89

u/ml

—

Schizophrenia or delusion

758

5279

1.46

20.70

1.1

1.16

7.37

u/ml

0.78

Menorrhagia

959

3789

1.42

20.69

1.1

10.43

11.10

u/ml

0.02

Sulfasalazine

681

4650

1.49

20.63

1.1

0.92

5.48

u/ml

—

Fibroblastic disorders

450

2809

1.63

20.52

1.1

1.23

12.96

u/ml

—

Mixed connective tissue disease

189

915

2.15

20.34

1.1

1.73

0.96

u/ml

—

Schizophrenia, schizotypal and delusional disorders

758

5297

1.45

20.33

1.1

1.16

10.39

u/ml

1.06

Abnormal involuntary movements

318

1822

1.79

20.32

1.1

4.86

1.85

u/ml

—

Psoriasis

632

4276

1.50

20.10

1.1

26.11

11.52

u/ml

0.37

Memory loss

200

990

2.08

20.08

1.1

—

0.93

—

Cutaneous abscess, furuncle and carbuncle

591

3949

1.52

20.01

1.1

11.76

13.43

u/ml

—

Disorders of lens

1421

6857

1.32

20.01

1.1

1.65

7.11

u/ml

0.88

114

Acetic acid derivatives and related substances

663

2304

1.52

20.00

1.1

0.99

6.47

u/ml

—

Viral and other specified intestinal infections

623

4112

1.51

19.96

1.1

1.04

9.68

u/ml

—

Tonsillectomy and adenotomy

1627

8858

1.29

19.94

1.1

5.24

11.75

u/ml

0.60

141

Congenital malformations, deformations and chromosomal abnormalities

1548

11582

1.29

19.89

1.1

3.22

12.57

u/ml

1.38

164

1276

8683

1.33

19.88

1.1

14.45

7.95

u/ml

0.19

121

Overexertion and strenuous or repetitive movements

250

1342

1.92

19.84

1.1

—

0.87

—

Coxarthrosis

958

4699

1.40

19.77

1.1

0.93

14.48

u/ml

1.41

Sleep apnoea

2045

11146

1.25

19.59

1.1

13.71

6.16

u/ml

0.27

178

Substance abuse

1240

9001

1.33

19.55

1.1

22.97

7.41

u/ml

0.45

127

Rheumatoid arthritis, including avohilmo

846

6072

1.41

19.52

1.1

15.14

7.87

u/ml

0.20

Other disorders of eyelid

871

6062

1.40

19.49

1.1

37.50

4.15

u/ml

0.42

Tinnitus

518

3391

1.56

19.36

1.1

1.28

7.39

u/ml

—

Fracture of lumbar spine and pelvis

420

2615

1.63

19.35

1.1

11.93

1.14

u/ml

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

468

2998

1.59

19.33

1.1

1.42

1.92

u/ml

—

Keratitis

788

5604

1.43

19.19

1.1

4.53

9.60

u/ml

0.39

Diseases of male genital organs

960

3500

1.40

19.06

1.1

32.11

13.97

u/ml

0.25

L04AD Calcineurin inhibitors

284

1609

1.82

19.01

1.1

85.50

1.38

u/ml

—

Chronic periapical parodontitis

418

2616

1.63

18.96

1.1

0.90

9.28

u/ml

—

Transport accidents

1095

7270

1.35

18.93

1.1

5.17

9.32

u/ml

0.48

128

Bacterial pneumonia, not elsewhere classified

825

5229

1.41

18.91

1.1

7.71

5.59

u/ml

—

Atrial fibrillation and flutter with reimbursement

563

2378

1.54

18.90

1.1

72.24

3.71

u/ml

—

Cervicocranial syndrome

257

1414

1.86

18.83

1.1

1.03

2.62

u/ml

—

Abrasion of teeth

660

3328

1.48

18.81

1.1

17.66

7.52

u/ml

0.25

Impingement syndrome of shoulder

506

3316

1.55

18.76

1.1

0.92

12.34

u/ml

0.98

Lichen simplex chronicus and prurigo

160

749

2.22

18.73

1.1

2.54

0.93

u/ml

—

Bleeding

1764

10209

1.27

18.67

1.1

4.73

11.23

u/ml

0.67

141

Other cataract

872

4878

1.40

18.61

1.1

1.63

5.16

u/ml

0.58

Polyarthrosis

406

2431

1.63

18.50

1.1

0.92

1.65

u/ml

0.73

Biological medication for rheuma

402

2515

1.64

18.46

1.1

33.46

13.67

u/ml

—

1196

8368

1.32

18.37

1.1

15.89

8.30

u/ml

0.21

115

Acute bronchitis

907

6512

1.38

18.37

1.1

2.81

13.04

u/ml

0.94

Bacterial pneumoniae

869

5586

1.39

18.36

1.1

31.63

5.26

u/ml

—

Seropositive rheumatoid arthritis

551

3688

1.51

18.29

1.1

23.04

6.50

u/ml

—

Influenza and pneumonia

2653

14500

1.21

18.24

1.1

15.07

9.32

u/ml

0.25

223

Renal tubulo-interstitial diseases

2028

12615

1.24

18.20

1.1

15.13

8.21

u/ml

0.31

183

Psoriasis vulgaris

408

2568

1.62

18.18

1.1

47.26

10.09

u/ml

—

Other extrapyramidal and movement disorders in other diseases

467

3032

1.57

18.17

1.1

2.50

1.46

u/ml

—

Benign neoplasm: Rectum

342

2065

1.69

18.01

1.1

1.44

1.72

u/ml

—

Mental and behavioural disorders due to psychoactive substance use

1271

9252

1.31

17.91

1.1

22.97

7.08

u/ml

0.46

134

Fissure and fistula of anal and rectal regions

509

3376

1.53

17.86

1.1

3.97

12.63

u/ml

0.57

Deviated nasal septum

642

4458

1.46

17.75

1.1

1.22

15.72

u/ml

—

Coxarthrosis [arthrosis of hip](FG)

1036

5596

1.35

17.70

1.1

0.91

12.56

u/ml

1.43

Benign neoplasm: Rectum

342

2076

1.68

17.66

1.1

1.44

9.00

u/ml

—

Extrapyramidal and movement disorders

722

5134

1.42

17.62

1.1

1.68

4.92

u/ml

0.47

Ischaemic heart disease, wide definition

1566

7727

1.28

17.52

1.1

12.63

7.57

u/ml

0.19

118

Other disorders of veins

861

6308

1.38

17.51

1.1

23.28

7.62

u/ml

0.31

Diabetic retinopathy, excluding more controls

615

2365

1.49

17.24

1.2

1.1

15.20

10.82

u/ml

—

Plantar fascial fibromatosis

228

1247

1.88

17.10

1.1

1.46

3.01

u/ml

—

Brachial plexus disorders

240

1335

1.85

17.09

1.1

2.10

2.60

u/ml

—

Sequelae with surgical and medical care as external cause

416

2672

1.59

17.03

1.1

2.45

1.74

u/ml

—

703

4701

1.42

17.02

1.1

6.49

5.27

u/ml

0.07

Other bacterial diseases

2138

12125

1.23

17.01

1.1

25.95

8.15

u/ml

0.68

174

Benign neoplasm: Rectum, anus and anal canal

379

2382

1.62

17.00

1.1

1.34

1.59

u/ml

—

Benign neoplasm of other and ill-defined parts of digestive system

372

2332

1.63

16.93

1.1

2.77

1.80

u/ml

—

Rash and other nonspecific skin eruption

253

1435

1.81

16.91

1.1

0.93

1.35

u/ml

—

Fracture of rib(s), sternum and thoracic spine

544

3701

1.49

16.86

1.1

1.28

11.86

u/ml

0.87

Acute tubulo-interstitial nephritis

1417

9903

1.28

16.84

1.1

15.85

7.27

u/ml

0.25

140

Exclusions for E4_PCOS_BROAD

441

2881

1.56

16.79

1.1

1.10

12.20

u/ml

—

Benign neoplasm of other and ill-defined parts of digestive system

372

2337

1.62

16.78

1.1

2.77

1.42

u/ml

—

Atrial fibrillation and flutter

687

3152

1.44

16.76

1.1

40.62

3.14

u/ml

—

Other disorders of teeth and supporting structures

423

2737

1.57

16.69

1.1

1.10

9.14

u/ml

—

Urticaria and erythema

916

6837

1.36

16.67

1.1

1.55

9.50

u/ml

0.92

Other diseases of the digestive system

569

3913

1.47

16.65

1.1

1.64

1.05

u/ml

0.80

TMD related operations

407

2619

1.59

16.61

1.1

0.90

11.73

u/ml

—

Other disorders of fluid, electrolyte and acid-base balance

560

3703

1.48

16.59

1.1

0.86

8.55

u/ml

0.63

Bacterial pneumonia (organism specified)

892

6028

1.36

16.53

1.1

31.62

4.68

u/ml

—

GI-bleeding

569

3920

1.47

16.49

1.1

1.64

1.05

u/ml

0.79

Other maternal disorders predominantly related to pregnancy

1577

7897

1.27

16.45

1.1

3.60

5.13

u/ml

0.26

122

Benign neoplasm: Rectum, anus and anal canal

379

2402

1.61

16.43

1.1

1.34

8.29

u/ml

—

Adverse effects, not elsewhere classified

501

3380

1.51

16.40

1.1

47.67

3.63

u/ml

—

Type 2 diabetes, strict (exclude DM1)

2072

10131

1.23

16.35

1.1

20.92

5.23

u/ml

0.59

167

Thyrotoxicosis

586

4075

1.46

16.35

1.1

1.49

2.25

u/ml

0.39

Other symptoms and signs involving the nervous and musculoskeletal systems

954

7182

1.34

16.32

1.1

2.80

7.72

u/ml

0.63

103

Complications of internal orthopaedic prosthetic devices, implants and grafts

430

2808

1.56

16.32

1.1

1.15

1.81

u/ml

—

Type 2 diabetes, definitions combined, including avohilmo

2091

10148

1.23

16.32

1.1

22.52

5.23

u/ml

0.61

167

Hallux valgus (acquired)

741

3860

1.41

16.13

1.1

1.14

7.75

u/ml

—

Internal derangement of knee

797

5837

1.38

16.03

1.1

3.14

15.45

u/ml

1.28

Type 2 diabetes, definitions combined

2061

10090

1.23

16.01

1.1

21.69

5.23

u/ml

0.60

167

Lesion of ulnar nerve

286

1702

1.71

15.98

1.1

18.96

1.87

u/ml

0.44

Heart failure, not strict

1540

8470

1.26

15.91

1.1

17.97

9.10

u/ml

0.30

128

Mental and behavioural disorders due to alcohol, excluding acute intoxication

870

6484

1.35

15.76

1.1

26.51

9.75

u/ml

0.28

Alcohol abuse, main dg, excluding more controls

305

1854

1.67

15.69

1.1

1.44

10.45

u/ml

—

Hyperplasia of prostate

529

2031

1.50

15.68

1.1

2.04

18.66

u/ml

—

Glucosamine medication

967

5830

1.34

15.67

1.1

1.36

4.33

u/ml

0.51

Skin changes due to chronic exposure to nonionizing radiation

648

4362

1.42

15.67

1.1

7.03

5.54

u/ml

0.08

Implicit bacterial Sepsis

698

4610

1.40

15.62

1.1

2.50

5.33

u/ml

0.36

Allergic rhinitis

854

6314

1.36

15.58

1.1

26.80

6.89

u/ml

0.34

Injuries to the shoulder and upper arm

1840

12621

1.23

15.50

1.1

13.86

7.52

u/ml

0.20

185

Disorders of refraction and accommodation

686

4941

1.40

15.39

1.1

49.78

7.93

u/ml

—

Actinic keratosis

623

4195

1.43

15.36

1.1

7.03

5.54

u/ml

0.08

Striking against or struck by other objects

748

5479

1.38

15.35

1.1

4.68

11.23

u/ml

—

Benign neoplasm: Stomach

211

1168

1.86

15.31

1.1

0.82

1.35

u/ml

—

Tumor necrosis factor alpha inhibitors

358

2283

1.60

15.28

1.1

38.90

14.64

u/ml

—

Gonarthrosis,primary

1790

9158

1.24

15.27

1.1

1.79

8.60

u/ml

1.37

153

Benign neoplasm: Ascending colon

250

1454

1.76

15.26

1.1

2.80

1.24

u/ml

—

Female infertility, cervigal, vaginal, other or unspecified origin

757

3693

1.39

15.24

1.1

2.11

11.52

u/ml

0.56

Mental and behavioural disorders due to alcohol

1029

7688

1.31

15.21

1.1

21.13

8.18

u/ml

0.27

110

Thyrotoxicosis, other and/or unspecified

465

3138

1.51

15.21

1.1

1.56

1.78

u/ml

—

Benign neoplasm: Ascending colon

250

1457

1.75

15.15

1.1

2.80

1.29

u/ml

—

Other and unspecified visual disturbances

225

1275

1.81

15.14

1.1

56.68

1.40

u/ml

—

Benign neoplasm: Stomach

211

1173

1.85

15.10

1.1

0.82

1.38

u/ml

—

Senile cataract

1229

5950

1.29

14.97

1.1

1.71

4.52

u/ml

0.58

102

Mycoses

560

3926

1.45

14.96

1.1

1.80

13.27

u/ml

—

Other disorders of ear

2074

11451

1.21

14.89

1.1

3.62

10.05

u/ml

0.97

169

Substance use, excluding alcohol

442

2965

1.52

14.86

1.1

15.28

9.39

u/ml

—

All pneumoniae

2445

14209

1.19

14.81

1.1

18.50

7.35

u/ml

0.46

222

Seronegative rheumatoid arthritis

264

1572

1.72

14.81

1.1

0.92

2.29

u/ml

—

Bacterial Sepsis

824

5467

1.35

14.79

1.1

2.24

5.32

u/ml

0.50

Benign neoplasm: Sigmoid colon

338

2140

1.61

14.78

1.1

1.02

1.81

u/ml

—

Infections with a predominantly sexual mode of transmission

790

5873

1.36

14.78

1.1

18.95

13.18

u/ml

0.11

Cholera

115

521

2.30

14.78

1.1

—

0.90

—

Cerebrovascular diseases (FINNGEN)

691

3570

1.40

14.77

1.1

64.88

3.10

u/ml

—

Diplopia

278

1680

1.69

14.75

1.1

6.03

1.20

u/ml

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

501

2384

1.49

14.72

1.1

28.73

3.49

u/ml

—

Biguanides

2098

10728

1.21

14.67

1.1

22.50

4.98

u/ml

0.62

172

Anti-inflammatory and antirheumatic products, non-steroids

767

2804

1.39

14.66

1.1

2.24

14.06

u/ml

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

950

7261

1.32

14.54

1.1

4.24

11.39

u/ml

0.72

108

Urticaria

754

5586

1.37

14.54

1.1

1.79

11.79

u/ml

—

Benign neoplasm: Sigmoid colon

338

2152

1.60

14.45

1.1

1.02

8.46

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1099

5396

1.30

14.40

1.1

14.42

4.40

u/ml

0.35

Other and unspecified disorders of vitreous body

811

6046

1.35

14.40

1.1

1.92

4.08

u/ml

0.36

Other problems related to primary support group, including family circumstances

376

2402

1.57

14.33

1.1

20.42

16.93

u/ml

—

Female genital prolapse

708

2964

1.40

14.29

1.1

1.34

2.22

u/ml

0.56

Diseases of inner ear

1094

8366

1.29

14.25

1.1

1.73

6.64

u/ml

0.86

128

Other neurological diseases

1449

9378

1.25

14.21

1.1

2.57

6.43

u/ml

0.66

144

Fracture of lower leg, including ankle

1205

9494

1.28

14.18

1.1

4.44

8.49

u/ml

0.42

132

Childhood asthma (age<16), excluding more controls

441

2356

1.51

14.15

1.1

1.33

2.89

u/ml

—

Propionic acid derivatives

763

2804

1.38

14.15

1.1

2.09

14.06

u/ml

—

Injuries to the neck

518

3620

1.45

14.14

1.1

51.07

2.60

u/ml

—

Ganglion

471

3233

1.48

14.11

1.1

0.88

8.95

u/ml

0.70

Childhood asthma (age<16)

441

2360

1.51

14.07

1.1

1.33

2.89

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

2418

14160

1.19

14.05

1.1

18.50

7.38

u/ml

0.46

221

Hyperlipidaemia, other/unspecified

662

4563

1.39

13.98

1.1

2.15

6.76

u/ml

—

Erysipelas

1044

7403

1.30

13.98

1.1

27.65

8.00

u/ml

0.34

107

Renal failure

732

4948

1.36

13.95

1.1

37.41

5.09

u/ml

0.64

Lactose intolerance

103

460

2.35

13.81

1.2

1.1

—

1.03

—

Glomerular diseases

364

2384

1.55

13.76

1.1

20.64

11.31

u/ml

—

Injuries to the wrist and hand

2401

14737

1.19

13.76

1.1

28.32

8.27

u/ml

0.55

239

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

489

3398

1.46

13.76

1.1

1.06

8.00

u/ml

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

407

5264

0.67

13.75

1.1

1.02

8.90

u/ml

—

Oxicams

464

1780

1.50

13.73

1.1

0.82

7.53

u/ml

—

Benign neoplasm: Transverse colon

191

1061

1.84

13.72

1.1

2.86

1.36

u/ml

—

Other hammer toe(s) (acquired)

350

2129

1.57

13.68

1.1

1.00

1.72

u/ml

—

Female infertility

824

3818

1.35

13.62

1.1

2.06

11.33

u/ml

0.57

Other inflammation of vagina/vulva

124

601

2.16

13.58

1.1

—

0.97

—

Cluster headache, wide

108

495

2.27

13.52

1.1

—

0.84

—

Lateral epicondylitis

287

1791

1.63

13.41

1.1

0.75

13.10

u/ml

—

Enthesopathies of lower limb, excluding foot

458

3162

1.47

13.33

1.1

73.04

8.24

u/ml

—

Cluster headache, strict

103

466

2.30

13.33

1.1

—

0.84

—

Specific development disorders of scholastic skills

178

974

1.89

13.29

1.1

1.2

—

2.61

—

Persons encountering health services in circumstances related to reproduction

1443

7923

1.24

13.15

1.1

6.77

13.08

u/ml

0.54

122

Melanocytic naevi

658

4850

1.37

13.15

1.1

4.06

5.49

u/ml

0.13

Disorders of vestibular function (Vertigo)

932

7164

1.30

13.14

1.1

1.85

7.24

u/ml

0.81

111

Coagulation defects, purpura and other haemorrhagic conditions

416

2831

1.49

13.12

1.1

1.82

2.68

u/ml

—

Inflammatory bowel disease

712

5315

1.36

13.06

1.1

29.29

5.57

u/ml

0.48

Paralytic ileus and intestinal obstruction

435

2986

1.47

12.97

1.1

1.03

6.90

u/ml

—

Conjunctivitis (acute, non atopic)

671

4960

1.37

12.90

1.1

21.77

7.26

u/ml

0.30

Medical abortion

1723

7722

1.22

12.82

1.1

1.52

3.67

u/ml

0.91

120

Bacterial intestinal infections, IBD co-morbidities

357

2365

1.53

12.81

1.1

1.10

1.65

u/ml

—

Other general symptoms and signs

154

814

1.94

12.69

1.1

—

46.64

u/ml

—

Disorders of breast

1217

9065

1.26

12.55

1.1

5.64

3.45

u/ml

0.20

127

Thyrotoxicosis with diffuse goitre

337

2220

1.55

12.52

1.1

1.88

1.84

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2078

11397

1.19

12.52

1.1

16.43

6.97

u/ml

0.40

160

Seborrhoeic keratosis

408

2792

1.48

12.49

1.1

57.93

1.64

u/ml

—

Alcohol use disorder, ICD-based

785

5978

1.33

12.49

1.1

28.96

10.06

u/ml

—

Pregnancy examination and test

501

2199

1.45

12.49

1.1

1.03

2.25

u/ml

—

Injuries to the head

2665

14932

1.17

12.43

1.1

7.99

10.60

u/ml

0.16

220

Triptan medication for migraine, min. 3 purchases

1473

9522

1.23

12.42

1.1

1.15

10.26

u/ml

1.60

148

Fracture of shoulder and upper arm

753

5712

1.33

12.33

1.1

1.70

5.86

u/ml

—

Fall on and from stairs and steps

529

3806

1.41

12.31

1.1

2.05

8.21

u/ml

—

Ischemic heart diseases

1546

7944

1.23

12.28

1.1

13.18

7.40

u/ml

0.22

121

All influenza

526

3782

1.41

12.25

1.1

51.32

7.96

u/ml

0.66

Other disorders of bladder

213

1262

1.72

12.23

1.0

1.1

1.99

0.95

u/ml

—

Heart failure and antihypertensive medication

469

2160

1.45

12.16

1.1

45.09

3.95

u/ml

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2322

13928

1.18

12.11

1.1

18.50

7.10

u/ml

0.48

215

Benign neoplasm: Transverse colon

191

1104

1.77

12.06

1.1

2.86

1.39

u/ml

—

Injuries to the elbow and forearm

1648

12387

1.21

12.05

1.1

5.91

9.33

u/ml

0.36

185

Melanocytic naevi

658

4920

1.35

12.02

1.1

4.06

2.25

u/ml

0.30

Intracranial injury

1257

9845

1.24

11.96

1.1

2.08

11.77

u/ml

1.48

130

Exclusions for E4_PCOS_CONSORTIUM

1939

10224

1.20

11.93

1.1

1.24

11.94

u/ml

1.81

157

Diabetic retinopathy

687

3239

1.36

11.88

1.1

13.39

14.54

u/ml

—

Bacterial infection, other or unspecified

998

7110

1.28

11.84

1.1

20.67

8.26

u/ml

0.35

103

Acute renal failure

338

2253

1.52

11.79

1.1

55.26

7.56

u/ml

—

Early onset COPD, excluding more controls

363

2453

1.50

11.79

1.1

43.71

8.78

u/ml

—

Neuralgia and neuritis, unspecified

118

590

2.06

11.78

1.1

—

0.87

—

Superficial injury of wrist and hand

482

3444

1.42

11.76

1.1

4.91

9.47

u/ml

—

Other (seronegative) rheumatoid arthritis, wide

392

2700

1.47

11.68

1.1

22.94

1.73

u/ml

—

Acute appendicitis

1587

12452

1.21

11.66

1.1

9.05

9.63

u/ml

0.02

185

Obesity due to excess calories

1058

8453

1.26

11.63

1.1

1.03

12.97

u/ml

1.53

115

Other disorders of patella

394

2719

1.47

11.61

1.1

1.89

12.30

u/ml

—

Hypo-osmolality and hyponatraemia

298

1935

1.56

11.60

1.1

0.83

1.73

u/ml

—

Glucagon-like peptide-1 (GLP-1) analogues

993

6457

1.28

11.58

1.1

36.91

5.67

u/ml

0.68

108

Localized swelling, mass and lump of skin and subcutaneous tissue

643

4823

1.35

11.49

1.1

1.10

5.85

u/ml

0.70

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

539

3938

1.39

11.46

1.1

23.04

1.80

u/ml

—

Angina pectoris

1108

5982

1.26

11.40

1.1

18.59

9.42

u/ml

0.24

Otitis externa

480

3445

1.41

11.40

1.1

43.30

9.59

u/ml

—

Viral infections characterized by skin and mucous membrane lesions

905

7110

1.28

11.39

1.1

23.89

11.64

u/ml

0.25

103

Seropositive rheumatoid arthritis, wide

551

4053

1.38

11.23

1.1

23.04

1.77

u/ml

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2268

13214

1.17

11.21

1.1

17.20

7.90

u/ml

0.39

202

Disorder of lipoprotein metabolism, unspecified

229

1417

1.64

11.14

1.1

42.45

0.96

u/ml

—

Diseases of middle ear and mastoid

1435

9720

1.22

11.08

1.1

5.85

11.77

u/ml

0.58

140

False labour

847

4135

1.30

11.06

1.1

18.47

12.05

u/ml

0.14

Appendicitis, broad definition

1682

12920

1.20

11.04

1.1

8.64

9.78

u/ml

0.05

192

Lactose intolerance, other/unspecified

399

2.28

11.03

1.2

1.1

—

1.03

—

Other/unspecified seropositive rheumatoid arthritis

544

4006

1.37

11.02

1.1

23.04

1.78

u/ml

—

Dental caries 2 and operation codes, only avohilmo

1899

9980

1.19

10.90

1.1

8.24

8.80

u/ml

0.03

154

Dysplasia of cervi uteri

608

3512

1.36

10.89

1.1

32.29

11.09

u/ml

—

Superficial injury of lower leg

553

4092

1.37

10.89

1.1

5.47

1.49

u/ml

0.78

Other benign neoplasms of skin

732

5637

1.31

10.86

1.1

6.34

8.97

u/ml

0.14

Dislocation, sprain and strain of joints and ligaments at neck level

359

2470

1.48

10.84

1.1

59.18

2.16

u/ml

—

Other menopausal disorders

635

2734

1.36

10.81

1.1

1.94

2.41

u/ml

—

Polyp of the female genital tract

747

3326

1.32

10.76

1.1

1.03

2.98

u/ml

—

Diseases of appendix

1692

12990

1.19

10.76

1.1

8.64

9.66

u/ml

0.05

195

Other benign neoplasms of skin

732

5540

1.31

10.69

1.1

6.34

8.91

u/ml

0.14

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

648

4922

1.33

10.68

1.1

25.97

7.62

u/ml

—

Epilepsy

646

4893

1.33

10.59

1.1

1.16

12.86

u/ml

1.02

Abnormal findings on diagnostic imaging of lung

824

6293

1.29

10.52

1.1

12.95

8.17

u/ml

0.19

Unspecified haematuria

707

4649

1.31

10.49

1.1

32.56

10.96

u/ml

0.40

Methotrexate

325

2209

1.50

10.44

1.1

26.01

1.90

u/ml

—

Adalimumab

219

1369

1.64

10.39

1.1

46.56

1.56

u/ml

—

Diseases of external ear

686

5272

1.31

10.38

1.1

82.68

14.16

u/ml

—

Benign neoplasm: Skin of eyelid, including canthus

299

2004

1.52

10.31

1.1

0.99

1.83

u/ml

—

Fracture of femur

420

2729

1.42

10.30

1.1

3.18

1.50

u/ml

—

Candidiasis

295

1974

1.52

10.28

1.1

1.04

1.52

u/ml

—

Coronary atherosclerosis

1256

6638

1.23

10.24

1.1

13.16

8.92

u/ml

0.13

Unspecified lump in breast

376

2643

1.45

10.19

1.1

17.53

1.76

u/ml

—

Ulcerative colitis

522

3869

1.37

10.18

1.1

29.15

1.88

u/ml

0.53

Anorexia (incl.atypical)

185

1118

1.70

10.10

1.1

0.78

6.73

u/ml

—

Benign neoplasm: Skin of eyelid, including canthus

299

2013

1.51

10.09

1.1

0.99

1.38

u/ml

—

Blepharochalasis

539

4021

1.36

10.08

1.1

0.89

1.85

u/ml

—

Other strabismus

539

4018

1.36

10.01

1.1

26.35

9.00

u/ml

0.32

Endometriosis of pelvic peritoneum

393

2757

1.43

9.94

1.1

2.84

3.51

u/ml

—

Chronic kidney disease

452

3269

1.39

9.93

1.1

21.81

6.43

u/ml

—

Other symptoms and signs involving the circulatory and respiratory systems

137

764

1.83

9.87

1.1

—

1.65

—

Reactive arthropathies

184

1116

1.68

9.81

1.1

40.72

21.44

u/ml

—

Pollen allergy

528

3908

1.36

9.80

1.1

37.57

11.56

u/ml

0.30

Acute appendicitis, no complications

1251

10339

1.22

9.74

1.1

11.73

8.81

u/ml

0.10

147

Transient ischemic attack

916

6080

1.26

9.66

1.1

4.06

1.88

u/ml

0.35

Colectomy operation

298

2023

1.49

9.65

1.1

11.90

1.78

u/ml

—

Other abnormal products of conception

843

4453

1.27

9.53

1.1

16.32

5.16

u/ml

0.32

Paroxysmal tachycardia

509

3202

1.36

9.50

1.1

33.65

3.27

u/ml

0.59

Benign neoplasm: Caecum

183

1121

1.67

9.42

1.1

0.93

1.34

u/ml

—

Use of pramipexole

402

2900

1.40

9.35

1.1

1.29

1.63

u/ml

—

Injuries to the hip and thigh

857

6271

1.26

9.31

1.1

4.51

8.74

u/ml

—

Azathioprine

341

2395

1.45

9.29

1.1

4.73

1.77

u/ml

—

ILD medications: azathioprine

341

2396

1.44

9.27

1.1

4.73

1.84

u/ml

—

Benign neoplasm: Caecum

183

1128

1.65

9.20

1.1

0.93

1.43

u/ml

—

Other disorders of bone

431

3159

1.38

9.12

1.1

1.32

10.20

u/ml

—

Suppurative and unspecified otitis media

935

6714

1.25

9.09

1.1

4.79

14.10

u/ml

0.80

Haemorrhage in early pregnancy

690

5276

1.29

9.08

1.1

1.56

4.44

u/ml

0.55

Primary biliary cholangitis (PBC)

244

2.49

9.03

1.0

—

Invasive ventilation

152

899

1.73

9.00

1.1

—

1.36

u/ml

—

Allergic contact dermatitis

311

2164

1.46

8.95

1.1

1.85

3.16

u/ml

—

Impotence

398

2.11

8.92

1.1

—

0.76

—

Fracture of forearm

1237

9673

1.21

8.89

1.1

6.49

5.84

u/ml

0.05

145

Benign paroxysmal vertigo

546

4163

1.33

8.86

1.1

2.38

1.82

u/ml

—

Pneumonia, organism unspecified

2040

12805

1.16

8.78

1.1

19.61

7.90

u/ml

0.45

189

Superficial injury of head

461

3435

1.36

8.76

1.1

1.06

9.47

u/ml

—

Hernia of abdominal wall

834

6711

1.25

8.72

1.1

1.94

10.43

u/ml

1.09

103

Postmenopausal bleeding

576

2406

1.33

8.72

1.1

1.04

1.71

u/ml

—

Abnormal findings on diagnostic imaging of other body structures

257

1735

1.51

8.66

1.1

1.50

2.11

u/ml

—

Other noninflammatory disorders of uterus, except cervix

472

2401

1.36

8.52

1.1

14.77

1.71

u/ml

—

Other and unspecified tonsillitis

840

5746

1.25

8.49

1.1

2.91

13.16

u/ml

1.07

Other symptoms and signs involving the digestive system and abdomen

337

2403

1.42

8.45

1.1

1.10

1.51

u/ml

—

Ventral hernia

430

3189

1.36

8.45

1.1

1.05

6.71

u/ml

—

Other or unspecified ileus, impaction or obstruction

287

1988

1.46

8.38

1.1

1.06

9.08

u/ml

—

Idiopathic urticaria

286

2.31

8.31

1.1

—

1.04

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1230

8121

1.20

8.17

1.1

22.63

6.07

u/ml

0.54

134

Postmenopausal atrophic vaginitis

539

2474

1.33

8.17

1.1

0.90

1.71

u/ml

—

Pregnancy with abortive outcome

1744

7847

1.17

8.14

1.1

1.74

3.72

u/ml

0.84

122

Panniculitis affecting regions of neck and back

430

2.01

8.00

1.1

—

0.83

—

Colonic or urogenital fistula

520

3999

1.31

7.97

1.1

3.79

11.31

u/ml

0.52

Primary_lymphoid and hematopoietic malignant neoplasms

414

3083

1.36

7.95

1.1

23.19

7.25

u/ml

—

Otitis media, unspecified

333

2208

1.41

7.93

1.2

1.1

4.64

3.93

u/ml

—

Glaucoma

992

7198

1.22

7.91

1.1

0.93

7.16

u/ml

1.00

108

Strabismus

606

4752

1.29

7.91

1.1

26.35

8.30

u/ml

0.34

Missing teeth due to accident, extraction or parodontitis

206

1355

1.54

7.88

1.1

0.83

1.85

u/ml

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

420

3148

1.35

7.83

1.1

1.22

3.36

u/ml

—

Covid-19 suspected case

478

3648

1.33

7.80

1.1

27.76

2.93

u/ml

0.46

Nonsuppurative otitis media

635

4336

1.28

7.79

1.1

10.80

8.24

u/ml

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

6.08

7.78

1.3

1.1

—

Hypokalaemia

212

1408

1.53

7.77

1.1

0.93

u/ml

—

Other hearing loss

445

3301

1.34

7.76

1.1

0.97

1.56

u/ml

—

Other specified/unspecified bacterial intestinal infections

134

801

1.71

7.70

1.1

—

1.72

—

Childhood allergy (age < 16)

510

3236

1.32

7.68

1.2

1.1

2.75

16.84

u/ml

—

Alcohol abuse, main dg

305

2177

1.42

7.67

1.1

1.44

11.32

u/ml

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

188

2392

0.65

7.64

1.1

4.38

8.53

u/ml

—

Glaucoma suspect

640

5083

1.27

7.60

1.1

0.89

4.95

u/ml

—

Myopia

304

2175

1.42

7.60

1.1

88.62

2.86

u/ml

—

Dementia in Alzheimer disease

1304

0.53

7.54

1.1

0.97

1.05

u/ml

—

5-aminosalicylic acid

449

3413

1.33

7.53

1.1

55.43

1.62

u/ml

—

AV-block

257

1616

1.46

7.48

1.1

3.84

1.04

u/ml

—

Umbilical hernia

465

3556

1.32

7.45

1.1

2.56

14.80

u/ml

—

Other CVD

285

2019

1.43

7.44

1.1

2.14

1.16

u/ml

—

Contraceptive management

942

5470

1.22

7.43

1.1

8.18

7.21

u/ml

0.05

Other and unspecified urticaria

448

3417

1.33

7.39

1.1

2.05

10.68

u/ml

—

Viral warts

231

1581

1.49

7.38

1.2

1.1

35.74

3.11

u/ml

—

Appendectomy

1467

12169

1.17

7.38

1.1

10.32

10.02

u/ml

0.01

175

Intestinal stricture

517

4019

1.30

7.32

1.1

1.06

5.85

u/ml

—

Syphilis

268

2.24

7.31

1.1

—

0.80

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

161

1023

1.61

7.30

1.1

—

1.91

—

Primary_lymphoid and hematopoietic malignant neoplasms

414

3129

1.34

7.22

1.1

23.19

7.12

u/ml

—

Other disorders of binocular vision

208

2.44

7.15

1.1

—

Septicaemia

721

5622

1.24

7.08

1.1

18.33

8.96

u/ml

0.23

Radial styloid tenosynovitis [de Quervain]

126

760

1.70

7.05

1.1

—

0.86

—

Corneal ulcer

357

2653

1.36

7.04

1.1

1.14

11.17

u/ml

0.62

Vitamin deficiency

104

596

1.79

7.01

1.1

6.80

0.94

u/ml

—

Vitamin deficiency, wide

104

596

1.79

7.01

1.1

6.80

0.94

u/ml

—

Explicit Sepsis

779

6113

1.23

7.01

1.1

15.88

5.15

u/ml

0.33

Nontoxic goitre/thyroid nodule

597

4757

1.27

6.98

1.1

1.88

1.71

u/ml

0.07

Postprocedural disorders of nervous system

179

1178

1.55

6.97

1.1

1.14

3.26

u/ml

—

Cardiodefibrillation

545

4286

1.28

6.95

1.1

41.69

5.26

u/ml

—

Hard cardiovascular diseases

1496

8292

1.16

6.89

1.1

32.98

4.51

u/ml

0.67

132

Nontoxic multinodular goitre

390

2948

1.34

6.88

1.1

1.07

1.92

u/ml

—

Benign neoplasm of mouth and pharynx

206

1398

1.50

6.87

1.1

1.05

1.25

u/ml

—

Benign neoplasm of mouth and pharynx

206

1401

1.49

6.80

1.1

1.05

1.24

u/ml

—

Fitting and adjustment of other devices

340

4231

0.74

6.77

1.1

1.30

5.74

u/ml

—

Acute suppurative otitis media

689

5226

1.24

6.74

1.1

4.18

13.07

u/ml

0.72

Other spirochaetal diseases

496

3883

1.29

6.74

1.1

20.26

2.53

u/ml

—

Gestational diabetes (for exclusion)

952

5637

1.21

6.66

1.1

38.60

5.67

u/ml

0.41

Hypertrophy of breast in women and men

424

3265

1.31

6.58

1.1

1.46

2.65

u/ml

0.65

Other disorders of breast

291

2124

1.39

6.54

1.1

1.98

3.27

u/ml

—

Varicose veins

1211

7827

1.18

6.52

1.1

1.14

7.46

u/ml

1.12

119

Diseases of arteries, arterioles and capillaries

1143

7260

1.18

6.51

1.1

42.50

2.57

u/ml

0.76

110

Heterophoria

200

1369

1.49

6.48

1.1

6.08

4.65

u/ml

—

Cramp and spasm

103

605

1.75

6.42

1.1

—

0.92

—

Retinal detachments and breaks

587

4718

1.25

6.37

1.1

1.28

9.61

u/ml

—

Pyoderma gangrenosum

3.18

6.32

1.1

—

Gastric ulcer

262

1886

1.40

6.31

1.1

49.58

1.77

u/ml

—

Gastroduodenal ulcer

383

2916

1.32

6.27

1.1

31.36

1.68

u/ml

—

Unspecific neurodegenerative disorder

345

3148

0.75

6.23

1.1

1.11

1.16

u/ml

—

Other viral diseases

678

5546

1.23

6.13

1.1

30.73

7.54

u/ml

0.38

Autoimmune polyglandular failure

6.71

6.10

1.6

1.1

—

Hypermobility syndrome

144

934

1.58

6.09

1.1

—

0.84

—

Coxarthrosis, primary

1003

7394

1.18

6.04

1.1

0.90

6.95

u/ml

1.07

117

Other medical care

473

5821

0.79

6.03

1.1

0.96

9.09

u/ml

1.12

Other disorders of nervous system

119

738

1.64

6.02

1.1

—

1.41

u/ml

—

Meralgia paraesthetica

367

1.93

5.99

1.1

1.0

—

0.86

—

Other septicaemia

627

5019

1.23

5.94

1.1

19.94

9.33

u/ml

0.24

Macular pucker

231

1649

1.42

5.92

1.1

—

1.30

—

Other fall from one level to another

469

3710

1.28

5.90

1.1

0.88

14.69

u/ml

—

Dislocation, sprain and strain of joints and ligaments of knee

1330

10752

1.15

5.89

1.1

14.35

8.21

u/ml

0.23

151

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

539

4334

1.25

5.88

1.1

1.29

6.86

u/ml

—

Dementia

384

3428

0.77

5.87

1.1

1.82

1.23

u/ml

—

Seropositive rheumatoid arthritis, strict definition

296

2206

1.36

5.84

1.1

34.05

1.82

u/ml

—

LSIL lesion of the cervix uteri, vagina or vulva

329

2494

1.34

5.82

1.1

40.10

3.12

u/ml

—

Anomalies of dental arch relationship, including avohilmo

484

3457

1.27

5.81

1.1

1.76

3.50

u/ml

0.58

Other infectious diseases

137

889

1.57

5.73

1.1

66.32

1.67

u/ml

—

Extracorporeal dialysis

107

656

1.66

5.70

1.1

—

1.49

—

Hypertrophy of breast

386

2999

1.30

5.69

1.1

1.49

2.76

u/ml

0.60

Ankylosing hyperostosis [Forestier]

110

2.74

5.68

1.0

1.1

—

u/ml

—

Hydrocele

152

1010

1.52

5.64

1.1

—

16.30

—

Open wound of ankle and foot

197

1381

1.45

5.64

1.1

47.60

3.50

u/ml

—

Car occupant injured in other and unspecified transport accidents

390

3037

1.30

5.62

1.1

2.50

10.50

u/ml

—

Parodontitis, under 40 years, or operation codes

250

1829

1.39

5.62

1.1

1.24

12.34

u/ml

—

Any dementia

321

2969

0.76

5.54

1.1

1.82

1.01

u/ml

—

Parkinson's disease, excluding more controls

189

1283

1.45

5.53

1.1

2.36

1.46

u/ml

—

Parodontitis, under 40 years

249

1826

1.38

5.52

1.1

1.24

12.34

u/ml

—

Fracture of skull and facial bones

391

3053

1.29

5.50

1.1

1.08

9.98

u/ml

—

Open wound of head

966

8135

1.18

5.49

1.1

24.77

10.84

u/ml

0.27

112

Normotensive glaucoma

140

924

1.54

5.45

1.1

—

1.53

—

Retention of urine

486

3288

1.26

5.42

1.1

1.92

6.22

u/ml

—

Parodontitis or/and operation codes

1536

8048

1.14

5.40

1.1

3.52

6.90

u/ml

0.53

128

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

389

1.85

5.37

1.1

—

1.00

—

Eosinophilic disease (BM)

151

2.40

5.28

1.1

1.0

—

Parodontitis, operation under 40 years and operation codes

237

1738

1.38

5.28

1.1

1.24

13.54

u/ml

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1308

9350

1.15

5.27

1.1

20.06

7.04

u/ml

0.46

154

Marginal zone B-cell lymphoma

3.16

5.22

1.1

1.0

—

Polyglandular dysfunction

4.44

5.22

1.6

1.1

—

Spermatocele

585

1.66

5.21

1.1

—

21.22

—

IBD patients in KELA-register

466

3744

1.26

5.20

1.1

12.63

1.94

u/ml

—

Artificial joint operation, meniscal resection

1747

10356

1.13

5.20

1.1

12.11

6.44

u/ml

0.24

159

Polyarthritis, unspecified

422

1.79

5.19

1.0

1.1

—

2.00

—

Parodontitis, under 40 years and operation codes

236

1735

1.38

5.18

1.1

1.24

13.54

u/ml

—

Acute pharyngitis

346

2666

1.30

5.18

1.1

7.32

2.55

u/ml

—

Gingival hyperplasia

453

1.77

5.17

1.1

—

0.83

—

Injury of muscle and tendon at shoulder and upper arm level

578

4754

1.22

5.14

1.1

0.97

9.68

u/ml

—

Other nutritional anaemias

2.88

5.13

1.0

1.1

—

Acute and transient psychotic disorders

233

1711

1.38

5.12

1.1

1.32

17.21

u/ml

—

Otalgia

183

1296

1.44

5.05

1.1

2.40

24.76

u/ml

—

Herpesviral [herpes simplex] infections

229

1682

1.38

5.04

1.1

—

1.63

—

Primary gonarthrosis, bilateral

861

6424

1.18

5.04

1.1

2.27

4.17

u/ml

0.37

110

Unstable angina pectoris

574

3909

1.22

5.03

1.1

31.22

7.26

u/ml

—

Combinations of oral blood glucose lowering drugs

445

3570

1.26

5.03

1.1

2.18

8.16

u/ml

—

All influenza (not pneumonia)

290

2207

1.33

5.00

1.1

41.70

12.62

u/ml

—

Certolizumab pegol

263

2.02

4.99

1.1

—

Familial hypercholesterolemia, with ischemic heart disease

134

894

1.52

4.97

1.1

—

1.67

—

Early onset COPD

363

2850

1.28

4.94

1.1

43.71

8.12

u/ml

—

Calculus of kidney and ureter

475

3849

1.24

4.90

1.1

2.70

13.55

u/ml

—

Other viral diseases, not elsewhere classified

418

3335

1.26

4.90

1.1

4.11

11.65

u/ml

—

Urolithiasis

507

4137

1.23

4.90

1.1

2.70

12.86

u/ml

—

Lesion of radial nerve

401

1.78

4.85

1.1

—

0.84

—

Conductive and sensorineural hearing loss

1511

9299

1.13

4.77

1.1

4.74

8.16

u/ml

0.37

144

Use of anticholinesterases

253

2702

0.75

4.68

1.1

1.12

1.19

u/ml

—

N06DA Anticholinesterases

253

2702

0.75

4.68

1.1

1.12

1.19

u/ml

—

Myocardial infarction, without ST-elevation

544

4147

1.22

4.60

1.1

1.15

10.45

u/ml

0.89

Secondary malignant neoplasm of other and unspecified sites

118

0.00

4.60

0.0

1.1

—

Dementia, including avohilmo

433

3691

0.80

4.60

1.1

1.64

1.24

u/ml

0.31

Other predominantly sexually transmitted diseases, not elsewhere classified

388

3109

1.26

4.53

1.1

29.23

2.92

u/ml

—

Congenital iodine-deficiency syndrome/hypothyroidism

374

1.78

4.49

1.0

1.1

—

1.05

—

Endometriosis ASRM stages 1,2

404

3268

1.25

4.36

1.1

2.84

2.52

u/ml

—

All dysplastic lesions of the cervix uteri, vagina or vulva

675

5697

1.19

4.34

1.1

29.40

7.63

u/ml

0.51

Any dementia, excluding more controls

310

2735

0.78

4.27

1.1

1.82

1.01

u/ml

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Tissue transglutaminase IgG Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS